CXXC5 and breast carcinoma: If our interpretation is correct, it is conceivable that vitamin B2 stimulation elevates CXXC5 expression, representing an effective complement to cancer immunotherapy and a strategy for breast cancer patients to achieve immunotherapy survival, whereas downregulation of CXXC5 leads to insensitivity to PD-1 blockade.